TL;DR: UnitedHealthcare modified its Category III CPT Codes Medicare Advantage medical policy, effective March 2, 2026. Here's what billing teams need to do.
UnitedHealthcare updated its Category III CPT code coverage policy under policy code category-iii-cpt-codes. This policy governs reimbursement for emerging technology codes across dozens of specialties billed to UHC Medicare Advantage plans. The update reinforces how UHC applies medical necessity and experimental designations to Category III codes — and clarifies the layered coverage determination framework your billing team must follow before submitting claims.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | UnitedHealthcare |
| Policy | Category III CPT Codes – Medicare Advantage Medical Policy |
| Policy Code | category-iii-cpt-codes |
| Change Type | Modified |
| Effective Date | March 2, 2026 |
| Impact Level | High |
| Specialties Affected | Neurology, orthopedics, surgery, imaging, rehabilitation, and any specialty billing emerging technology codes to UHC Medicare Advantage |
| Key Action | Audit every Category III CPT code in your charge capture against the NCD/LCD/LCA lookup hierarchy before submitting claims on or after March 2, 2026 |
UnitedHealthcare Category III CPT Code Coverage Criteria and Medical Necessity Requirements 2026
The core issue here is simple: a Category III CPT code is not a coverage approval. It is a tracking code. The American Medical Association creates Category III codes to monitor the use of emerging technologies, services, and procedures. The existence of the code does not make the service covered.
UnitedHealthcare's coverage policy makes this explicit. Under Section 1862(a)(1)(A) of the Social Security Act, UHC can deny payment for any service that fails to meet medical necessity standards — even if a valid CPT code exists for it. This is the same statutory authority CMS uses to deny claims for services that are experimental, unproven, or not generally accepted in the medical community.
For a service to meet medical necessity under this policy, it must clear all four of these bars:
| # | Covered Indication |
|---|---|
| 1 | Consistent with the diagnosis or symptoms being treated |
| 2 | Necessary and consistent with generally accepted professional medical standards — meaning not experimental |
| 3 | Not furnished primarily for patient or provider convenience |
| 4 | Provided at the most appropriate level that can safely and effectively serve the patient |
If a service fails any one of those four tests, the claim is at risk. For Category III codes, that risk is higher than average — because by definition, these codes represent emerging services that haven't fully cleared the evidence bar yet.
The FDA Device Approval Rule
There's an additional layer your billing team needs to flag. If a Category III procedure involves a medical device, that device must have FDA marketing approval. Services using unapproved devices are considered investigational under this coverage policy. UHC will not reimburse them under Medicare Advantage unless the procedure is performed in an approved FDA Investigational Device Exemption (IDE) trial. If your practice is billing Category III codes tied to devices, confirm FDA approval status before the effective date of March 2, 2026.
The Lookup Hierarchy That Governs Coverage
UHC does not resolve every Category III code with a blanket policy. Instead, billing teams must follow a specific lookup sequence. First, check the CMS Medicare Coverage Database for any applicable National Coverage Determination (NCD). If an NCD exists, that governs. If no NCD exists, check for a Local Coverage Determination (LCD) or Local Coverage Article (LCA) from the relevant Medicare Administrative Contractor (MAC). If neither exists, fall back to the UnitedHealthcare Medicare Advantage medical policy table for that specific code.
This three-tier hierarchy means your coverage answer depends on geography. A code covered in one MAC jurisdiction may be non-covered in another. Codes like 0106T, 0107T, 0108T, and 0109T — all quantitative sensory testing (QST) codes — illustrate this perfectly. For those codes, the First Coast LCD L34859 and Novitas LCD L35081 govern in their respective jurisdictions. In states with no applicable LCD or LCA, UHC directs billers to the UnitedHealthcare Commercial Medical Policy for Neurophysiologic Testing and Monitoring.
That's three possible paths to a coverage answer for a single code. If your billing team doesn't know which MAC covers your region, that's the first thing to fix.
UnitedHealthcare Category III CPT Code Exclusions and Non-Covered Indications
Category III codes carry a structural coverage disadvantage. Because they track emerging and experimental procedures, many do not meet UHC's medical necessity threshold under Section 1862(a)(1)(A). That statute gives UHC the authority to deny claims that are:
| # | Excluded Procedure |
|---|---|
| 1 | Not generally accepted in the medical community as safe and effective |
| 2 | Not proven by peer review or scientific literature |
| 3 | Experimental in nature |
| 4 | Not reasonable and necessary for the specific patient |
| 5 | Provided at an inappropriate level, duration, or frequency |
| 6 | Inconsistent with accepted standards of medical practice |
| 7 | Furnished in an inappropriate care setting for the patient's condition |
Any one of these criteria is sufficient for a claim denial. For Category III codes, the "not proven" and "experimental" categories are the most common triggers. These codes exist specifically because the evidence base is still developing. That's the purpose of Category III — to track utilization while evidence catches up to practice.
The real problem for billing teams: a physician may believe a service is clinically appropriate, document it thoroughly, and still receive a denial because the payer hasn't accepted the evidence base supporting that service. That disconnect is the central tension in Category III billing, and this policy update doesn't resolve it — it reinforces it.
Coverage Indications at a Glance
This table reflects the coverage framework from the policy. Because Category III codes are evaluated individually against NCD, LCD, LCA, and UHC policy criteria, coverage status depends on the code and MAC jurisdiction.
| Code | Description | Coverage Status | Governing Source | Notes |
|---|---|---|---|---|
| 0106T | QST, touch pressure stimuli, large diameter sensation | LCD-governed | First Coast L34859 / Novitas L35081 | No UHC NCD criteria; refer to UHC Commercial Policy for Neurophysiologic Testing where no LCD applies |
| 0107T | QST, vibration stimuli, large diameter fiber sensation | LCD-governed | First Coast L34859 / Novitas L35081 | No UHC NCD criteria; refer to UHC Commercial Policy for Neurophysiologic Testing where no LCD applies |
| 0108T | QST, cooling stimuli, small nerve fiber sensation/hyperalgesia | LCD-governed | First Coast L34859 / Novitas L35081 | No UHC NCD criteria; refer to UHC Commercial Policy for Neurophysiologic Testing where no LCD applies |
| 0109T | QST, heat-pain stimuli, small nerve fiber/hyperalgesia | LCD-governed | First Coast L34859 / Novitas L35081 | No UHC NCD criteria; refer to UHC Commercial Policy for Neurophysiologic Testing where no LCD applies |
| All other Category III codes | Varies by code | Determined by NCD → LCD/LCA → UHC policy lookup | CMS Medicare Coverage Database first | Must follow three-tier lookup sequence before billing |
UnitedHealthcare Category III CPT Code Billing Guidelines and Action Items 2026
Here's what your billing team needs to do before and after March 2, 2026.
| # | Action Item |
|---|---|
| 1 | Map every Category III code in your charge capture to the three-tier lookup hierarchy. For each code you bill, document whether an NCD, LCD/LCA, or UHC policy table governs. Do this before March 2, 2026. If you don't know which MAC covers your region, find out now — coverage for codes like 0106T through 0109T varies by jurisdiction. |
| 2 | Confirm FDA device approval for any Category III procedure involving medical equipment. If the service uses a device that lacks FDA marketing clearance, it is investigational under this policy. The claim will be denied unless it's performed under an approved IDE trial. Check this before billing — not after a denial. |
| 3 | Review the UHC Medicare Advantage policy table for Category III codes that have no NCD or LCD. For states and territories where no local coverage determination exists, UHC routes billing guidelines to its own internal policy documents. Make sure your team knows which UHC Medical Policy applies to each code in those jurisdictions. |
| 4 | Update your medical necessity documentation templates for Category III services. For every Category III claim, documentation must show that the service is consistent with the diagnosis, consistent with accepted medical standards, not experimental, not provided for convenience, and provided at the appropriate level of care. All four elements. Missing even one creates denial exposure. |
| 5 | Flag any Category III codes with prior authorization requirements in your practice management system. This policy does not list blanket prior authorization rules, but individual codes may trigger prior auth requirements under separate UHC Medicare Advantage policies. Check the UHC Medicare Advantage portal or the specific policy for each code before submitting. |
| 6 | Conduct a retrospective audit of Category III claims submitted in the last 90 days. If your team has been treating Category III codes as routinely covered, you likely have exposure. Pull claims, check them against the lookup hierarchy, and identify any patterns before they compound. |
| 7 | Talk to your compliance officer if you bill Category III codes in multiple MAC jurisdictions. The geographic variation in LCD and LCA coverage means a single billing workflow won't work across all regions. If you're not sure how this applies to your specific payer mix and state footprint, get your compliance officer involved before the effective date of March 2, 2026. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Category III Procedures Under category-iii-cpt-codes
The policy data provided does not include a consolidated code list. The policy explicitly references dozens of Category III CPT codes evaluated individually through the NCD/LCD/LCA lookup framework. The codes specifically referenced in the policy summary are:
Category III CPT Codes Referenced in Policy Summary
| Code | Type | Description | Coverage Pathway |
|---|---|---|---|
| 0106T | CPT Category III | Quantitative sensory testing (QST), testing and interpretation per extremity; using touch pressure stimuli to assess large diameter sensation | First Coast LCD L34859 / Novitas LCD L35081; UHC Commercial Policy for Neurophysiologic Testing where no LCD applies |
| 0107T | CPT Category III | Quantitative sensory testing (QST), testing and interpretation per extremity; using vibration stimuli to assess large diameter fiber sensation | First Coast LCD L34859 / Novitas LCD L35081; UHC Commercial Policy for Neurophysiologic Testing where no LCD applies |
| 0108T | CPT Category III | Quantitative sensory testing (QST), testing and interpretation per extremity; using cooling stimuli to assess small nerve fiber sensation and hyperalgesia | First Coast LCD L34859 / Novitas LCD L35081; UHC Commercial Policy for Neurophysiologic Testing where no LCD applies |
| 0109T | CPT Category III | Quantitative sensory testing (QST), testing and interpretation per extremity; using heat-pain stimuli to assess small nerve fiber sensation and hyperalgesia | First Coast LCD L34859 / Novitas LCD L35081; UHC Commercial Policy for Neurophysiologic Testing where no LCD applies |
Referenced LCD/LCA Documents
| Document | Jurisdiction | Relevant Codes |
|---|---|---|
| L34859 (A57123) | First Coast Service Options (FL, PR, USVI, and parts of SC) | 0106T–0109T |
| L35081 (A54095) | Novitas Solutions | 0106T–0109T |
The full policy covers additional Category III codes not included in the truncated summary provided. Access the complete policy at the UnitedHealthcare Medicare Advantage Medical Policy portal. Run each code through the CMS Medicare Coverage Database before billing.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.